Cart
sales@molnova.com
AG18
CAS No. 118409-57-7
AG18( RG-50810 | RG-50858 | TX 825 | Tyrphostin 23 | Tyrphostin AG-18 )
Catalog No. M10624 CAS No. 118409-57-7
AG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 49 | In Stock |
|
| 25MG | 112 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | 320 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG18
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
-
DescriptionAG-18(RG-50810; Tyrphostin A23) inhibits EGFR with IC50 of 35 μM.
-
In Vitro10 μM tyrphostin 23 causes significant inhibition of the cell proliferation caused by 1 nM and 1μM ghrelin. Tyrphostin 23 (T23) is a well-known inhibitor of protein tyrosine kinases and has been considered as potential anti-cancer drug. T23 is reported to acutely stimulate the glycolytic flux in primary cultured astrocytes. Tyrphostin 23 stimulates glycolytic flux in cultured astrocytes. Mitochondrial metabolism of brain astrocytes is accelerated by Tyrphostin 23 exposure.
-
In Vivo——
-
SynonymsRG-50810 | RG-50858 | TX 825 | Tyrphostin 23 | Tyrphostin AG-18
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number118409-57-7
-
Formula Weight186.17
-
Molecular FormulaC10H6N2O2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 37 mg/mL (198.74 mM); DMSO: 37 mg/mL (198.74 mM)
-
SMILESN#C/C(C#N)=C/C1=CC=C(O)C(O)=C1
-
Chemical Name2-[(3,4-dihydroxyphenyl)methylene]-propanedinitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gazit A, et al. J Med Chem, 1989, 32(10), 2344-2352.
molnova catalog
related products
-
PD 089828
PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
-
AZD-9291 mesylate
A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.
-
Lazertinib
Lazertinib (YH25448, GNS-1480) is a highly potent, mutant-selective, irreversible, brain-penetrant and orally active EGFR tyrosine-kinase inhibitors for both the T790M mutation and activating EGFR mutations.
